DSM seeks algae omega-3 expansion for infant formula

DSM seeks algae omega-3 expansion for infant formula

DSM Nutritional Products has applied for an EU novel foods extension for a micro-algae-derived DHA (docosahexaenoic acid) omega-3 form to be used in infant formula products.

The application is for a different algae to that already approved and widely used in infant formula and marketed by DSM-owned Martek Biosciences (Crypthecodinium cohnii).

A UK Food Standards Agency (FSA) evaluation of the DSM application for the current algae (Schizochytrium sp.) concluded it was a, “safe and suitable vegetarian and sustainably produced alternative to fish oil for use in infant and follow-on formula in foods, PARNUTS and food supplement products as a source of the important LCP DHA.”

It is the sixth time a party has sought expansion of the original Martek Biosciences novel foods approval for Crypthecodinium cohnii.

The FSA’s Advisory Committee on Novel Foods and Processes (ACNFP) is calling for public comment on the application until October 20.

Glucose replacement

The UK FSA is also calling for comment on an application from UK start-up TDeltaS for a molecule called D-β-Hydroxybutyrate it says can replace lost glucose during sporting activity.

“D-β-Hydroxybutyrate is a 'ketone body' produced by the human body when a limited amount of glucose is available, such as during intense and prolonged physical exertion,” the FSA said.

It is being proposed for use in food supplements to wghich the FSA said there was no safety concern.

“The capacity of the human body to produce and utilize ketones, as well as the long history of use of ketogenic diets, also support the safety of D-β-Hydroxybutyrate ester for its intended use.”

An EU novel food is a food or food ingredient that does not have a significant history of consumption within the European Union before 15 May 1997.

Related News

Norwegian omega-3 players enter UK; develop hard tablets

Norwegian omega-3 players enter UK; develop hard tablets

DSM profits rise 27% but nutrition sees ‘sluggish development’

DSM profits rise 27% but nutrition space ‘sluggish’ as omega-3 bites

DSM: A “confluence of completely unrelated events” has affected its 2013 results

DSM profits rise in 2013 despite sluggish nutrition performance

FSA invites comments on novel food application for cycloastragenol

FSA invites comments on novel food application for cycloastragenol

New data from the DOLAB study has linked blood levels of DHA to sleep quality, while preliminary RCT data has found supplementation may help.

Omega-3 status linked to sleep quality in school children: New data

Omega-3 rich infant formula may boost later intelligence: Study

Omega-3 rich infant formula may boost later intelligence: Study

Omega-3 levels linked to cognition and behavior in schoolchildren: Oxford University study

Omega-3 levels linked to cognition and behavior in schoolchildren: Oxford University study

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.